Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat
- 1 May 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (5), 1882-1894
- https://doi.org/10.1046/j.1523-1755.2000.00038.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Increased bradykinin and “normal” angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 ratsKidney International, 1999
- Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cellsKidney International, 1999
- A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)Kidney International, 1998
- Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin IIHypertension, 1996
- Renin processing and secretion in adrenal and retina of transgenic (mREN-2)27 ratsKidney International, 1994
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionKidney International, 1993
- Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs.Hypertension, 1993
- Production of rat renin fusion protein in Escherichia coli and the preparation of renin-specific antiseraMolecular and Cellular Endocrinology, 1990
- Short and long term effects of antihypertensive therapy in the diabetic ratKidney International, 1989